课题基金 / 基金详情

CALBINDIN-D28K--ROLE IN NEURODEGENERATION

CALBINDIN-D28K--ROLE IN NEURODEGENERATION
CALBINDIN-D28K——在神经退行性疾病中的作用
批准号:
2268394
负责人:
DWIGHT C. German
金额:
$29.7万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-08-01 至 1996-07-31

项目摘要

项目成果

DWIGHT C. German的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Calbindin-D28k (CaBP), a calcium-binding protein that is present in defined neuronal populations in the brain and spinal cord, appears to protect cells from calcium-mediated cellular degeneration. CaBP is found in the hippocampal neurons that are spared cell loss caused by experimentally induced seizures and excitotoxins. The neurons that do not contain CaBP appear to die as a result of toxic levels of intracellular Ca2+. Recent data from our laboratory indicate that the specific midbrain dopaminergic (DA) neurons that contain CaBP are preserved in patients with Parkinson's disease, and in monkeys and mice treated with 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine (MPTP, a neurotoxin which produces a parkinsonian syndrome). However, those DA neurons that do not contain CaBP are most vulnerable to Parkinson's disease and MPTP. The purpose of the present grant is-to determine whether CaBP protects midbrain DA neurons from the neurotoxic effects of MPTP in the mouse. First, we will use immunohistochemical staining for CaBP, computer imaging, CaBP in situ hybridization, 14C-MPTP in vivo autoradiography, and monoamine biochemical measuring techniques to determine whether endogenous CaBP protects specific midbrain DA neurons from MPTP-induced degeneration. Secondly, we will develop animal models in which to test the protective effects of CaBP against MPTP by generating transgenic mice which express CaBP within all of the midbrain DA neurons. We will use the tyrosine hydroxylase promoter and the neuron specific enolase promoter to ex-press CaBP, and determine whether the presence of this protein will specifically protect MPTP-sensitive areas of the midbrain (substantia nigra). These experiments will: (I) determine whether CaBP protects midbrain DA neurons from MPTP-induced parkinsonism; and (2) provide animal models of other neurodegenerative diseases where calcium-mediated neurodegeneration may play a major etiologic role (e.g., Alzheimer's disease, Huntington's disease).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biomarkers to Track Effective Interventions that Delay Dementia Onset in Participants of the "Risk Reduction for Alzheimer's Disease (rrAD)" Trial
  • 批准号:
    10746197
  • 项目类别:
  • 资助金额:
    $229.78万
  • 财政年份:
    2023
  • 负责人:
    DWIGHT C. German
  • 依托单位:
Biomarkers to track effective interventions that delay dementia onset in participants of the "Risk Reduction for Alzheimer's Disease (rrAD)" trial
  • 批准号:
    10459779
  • 项目类别:
  • 资助金额:
    $71.45万
  • 财政年份:
    2021
  • 负责人:
    DWIGHT C. German
  • 依托单位:
Novel Method for Alzheimer's Disease Drug Discovery
  • 批准号:
    7915623
  • 项目类别:
  • 资助金额:
    $16.51万
  • 财政年份:
    2009
  • 负责人:
    DWIGHT C. German
  • 依托单位:
CALBINDIN-D28K--ROLE IN NEURODEGENERATION
  • 批准号:
    2268396
  • 项目类别:
  • 资助金额:
    $37.61万
  • 财政年份:
    1993
  • 负责人:
    DWIGHT C. German
  • 依托单位:
海外基金